packageBelotecan

belotecan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Belotecan is a topoisomerase I inhibitor investigated for treating ovarian cancer and small cell lung cancer. It is not an approved medicine and remains investigational, with no authorisation in the European Union.

Summary written by glm-5.3-flash from Wikidata Q4884574 and the WHO ATC classification; not checked by a person.

name:belotecan
ATC codes:L01CE04
DrugBank:DB12459
PubChem CID:6456014
ChEBI:135702
Wikidata:Q4884574
formula:C25H27N3O4
molar mass:433.508 g/mol (PubChem CID 6456014)
logP:1.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown